HOME News and Press, At Home Group Inc. From 05/17/21

Largest Stockholder Intends to Vote Against the Proposed Transaction with Hellman & Friedman Under Current Terms Believes the Transaction Grossly Undervalues the Company and Lacks a Meaningful Premium Outlines an Alternative Valuation Anal...

Choice Equities is a boutique hedge fund manager, investing in public equities with the mindset of an opportunistic businessperson. We invest this way because we believe it is the right way to pursue our primary goal of compounding capital safely over the long term. Choice Equities Fu...

Sam Zell's Equity Commonwealth (EQC) wins bidding war for Monmouth Real Estate Investment Corporation (MNR) but arbitrageurs are expecting more. Farm Bureau Property & Casualty Insurance Company bumps up its offer price for FBL Financial Group (FFG) to $61 per share from its previ...

Gainers: SemiLEDs (LEDS) +106%.Lexaria Bioscience (LEXX) +49%.Stealth BioTherapeutics (MITO) +38%.Liquidity Services (LQDT) +27%.Applied UV (AUVI) +25%.BioCryst Pharmaceuticals (BCRX) +21%.Avid Technology (AVID) +21%.Summit Wireless Technologies (WISA) +20%.WW International (WW) +20...

Home decor retailer At Home Group (NYSE: HOME) is getting acquired by private equity firm Hellman & Friedman, according to an official press release from the company. The buyout price is $36 per share, a healthy premium to where the stock traded yesterday. Because of this, At Ho...

After reports of PE firm Hellman & Friedman nearing a deal to acquiring At Home ([[HOME]] +14.2%) yesterday, the company entered into a definitive agreement to be acquired in an all-cash transaction valued at $2.8B, including debt assumption.Under agreement terms, At H...

At Home Stockholders to Receive $36.00 Per Share in Cash At Home Group Inc. (NYSE: HOME), the home décor superstore, today announced that it has entered into a definitive agreement to be acquired by funds affiliated with Hellman & Friedman (H&F), a premier globa...

Stealth BioTherapeutics (MITO) +58% after showcases data for Elamipretide.Luokung Technology Corp. (LKCO) +22% on announcing favorable ruling granting preliminary injunction.Nemaura Medical (NMRD) +23% on 200K sugarBEAT sensors order.American Shared Hospital Services (AMS) +28%...

At Home Group (HOME) is unlikely to see a competing bid after a report that PE firm Hellman & Friedman is close to a deal to buy the home-decor retailer for the mid $30s/share, according to Wells Fargo. At Home gained 16% in premarket trading.An At Home deal makes sense at this point...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investors, and good morning. We’re getting ready for another busy day of trading here at InvestorPlace . That means we’re listing out the biggest pre-market stock movers for Wednesday to start t...